Introduction
During the 2000/2001 winter season, the UK Department of Health advised hospitals to immunize healthy National Health Service (NHS) employees against influenza [1, 2] . In previous years, the national influenza immunization campaign focused on the elderly and other groups at high risk of complications and death from influenza [3] , leaving the offer of vaccine to occupational groups (who did not have specific medical indications) to the discretion of individual employers. Consequently, influenza immunization policy for health care workers varied between hospitals in the UK during the 1990s. For example, a cross-sectional survey in NHS occupational health departments showed that only 24% of 279 trusts offered influenza vaccine to personnel during the 1997/ 1998 influenza season [4] .
In Southampton University Hospitals Trust, influenza vaccine had been offered routinely to all employees since the early 1990s. However, immunization against influenza was not promoted actively and uptake among hospital staff was poor. By 1999, forward planning for winter pressures began to demand a more active approach to managing staff absence [5] , and a change in central guidance on immunizing healthy NHS employees was anticipated. A number of intervention studies, mainly in the USA, had achieved success in increasing influenza vaccine uptake among health care workers by exploring attitudes to immunization and targeting promotion accordingly [6] [7] [8] . However, these findings are not necessarily generalizable to hospital settings in the UK. We therefore carried out a two-part survey of health care workers before and during the 1999/2000 influenza season to explore the reasons for limited vaccine acceptance and whether, by addressing the barriers to immunization, uptake could be improved.
work on intensive care and coronary care units, oncology, admissions, elderly care and neurology wards, and the accident and emergency department. All medical staff joining Southampton University Hospitals NHS Trust on 1 August 1999 were invited to complete a selfadministered questionnaire at a pre-placement medical assessment in the occupational health (OH) department. Questionnaires were distributed to nurses by their ward sister. The questionnaire asked whether the subject intended to take up an offer of immunization against influenza that was to be funded and provided on-site by the trust. Subjects were also asked what factors might inhibit their uptake of influenza vaccine at work.
Part 2
Information derived from this pre-programme questionnaire was used to improve the promotion of influenza immunization and to plan a strategy for vaccine delivery by the trust's OH department during the 1999/2000 influenza season. During September 1999, influenza immunization was widely promoted within the trust using a number of methods. Specific publicity included: distribution of a leaflet describing the effectiveness of the vaccine in preventing episodes of influenza and its side-effect profile; a memo to all wards and departments describing the arrangements for vaccine delivery by the OH team; notices on the hospital intra-net and on noticeboards; distribution of information about the vaccine and access to immunization in the formal managers' briefing to all staff; and an article in the staff newsletter. Departments were also offered a short presentation on influenza vaccine by a member of the OH team.
During October and November 1999, influenza vaccine was made available to all staff through booked or drop-in immunization clinics in the OH department, including special sessions arranged for staff working at night or outside office hours. In addition, ward-or department-based immunization sessions were offered to clinical areas with either vulnerable patients (e.g. elderly care, oncology) or a key strategic role in service delivery (e.g. accident and emergency, medical admissions unit, intensive care). Job title was recorded at the time of vaccination. In December 1999, a postal questionnaire was sent to all members of staff who had taken up the offer of influenza immunization during the preceding 2 month period. This post-programme questionnaire asked about job title and side-effects experienced following influenza immunization.
Results

Part 1
A total of 290 pre-programme questionnaires were completed. The response rates among doctors and nurses were 100 and 42%, respectively. Thirty-six per cent of responders stated their intention to take up influenza vaccine and 38% indicated their intention to decline. The remaining 26% were uncertain whether to accept immunization, but indicated that more information on vaccine effectiveness and side-effects might help them to decide. The proportion of doctors (41%) and nursing assistants (41%) who said that they would take up immunization was similar and slightly higher than the corresponding proportion of qualified nurses (31%). Table 1 shows the perceived barriers to influenza immunization by occupational group reported by subjects who intended to accept vaccine. Lack of time was the most commonly reported barrier to immunization by hospital staff. The perceived barriers were broadly similar among doctors and nurses, although a higher proportion of nurses perceived difficulty with practical access to immunization compared with doctors, whereas a higher proportion of doctors cited lack of time.
Among subjects who declared that they would not take up influenza vaccine, the most commonly cited reason for refusal was concern about side-effects (42% of those who chose to decline). Doctors were less likely to refuse vaccine because of possible side-effects than their nursing colleagues (36% of doctors who declined vaccine compared with 42% of nurses).
Part 2
During October and November 1999, 297 individuals were immunized using inactivated parenteral influenza vaccine. Of these, 214 (72%) replied to the postprogramme questionnaire. The distribution of job category among all vaccinees and among questionnaire responders was broadly similar (data not shown). Table 2 shows the overall uptake of influenza vaccine by hospital employees in successive years up to and including the study year (1999). Uptake was low during the years (1995, 1996, 1998) when vaccine was offered but not promoted. Uptake increased by~2-fold in two specific years when the vaccine was promoted actively (27) 27 (22) Some subjects perceived more than one barrier to immunization.
as part of this study (1999) or a related research project (1997). However, the proportion of all employees taking up influenza vaccine at work was still low (~5%), even with active promotion and a flexible delivery strategy. Table 3 shows the uptake of influenza vaccine according to job category recorded at vaccination for 1999 and 1998. In 1999, nurses accounted for~41% of vaccinees and almost 32% were administration and clerical staff; doctors accounted for <5% of health care workers who chose to take up immunization. This represents an uptake rate of only 4% among all nurses and <2% among all doctors employed by the trust. The greatest increase in uptake between the 2 years was among nurses and ancillary staff. The smallest increase in uptake was among doctors. Of the 13 doctors who were vaccinated in 1999, 10 were long-term employees. Only three of these were newly recruited in August 1999 and had responded to the Part 1 (pre-programme) questionnaire. Table 4 shows the incidence of reported side-effects following immunization. Among 214 who responded to the post-programme questionnaire, 56 (27%) reported having experienced at least one side-effect after receiving influenza vaccine. Of these, 54 provided information on the nature of their symptoms. The most commonly reported was local reaction, described by 28 subjects (13%). Although mild flu-like symptoms were relatively common (11%), severe flu-like symptoms were less frequently reported (4%).
A small number of responders said that they had to stay off work because of side-effects (n = 5, 2% of responders) and all of these reported severe flu-like symptoms. Between these five subjects, a total of 14 working days were missed.
Discussion
This survey in a typical UK acute teaching hospital found that 41% of newly recruited junior doctors and 33% of nursing staff employed in key clinical areas indicated willingness to accept influenza vaccine if it was offered in the workplace. The main reason for disinclination to accept vaccine was concern about vaccine-related sideeffects. Common perceived barriers to influenza immunization among doctors and nurses were difficulty in getting time off work to attend for immunization and limited practical access to the vaccine. In the USA, the Advisory Committee on Immunization Practices has advocated the provision of suitable educational material about influenza vaccine and the local delivery of vaccine at ward level to boost compliance among health care workers [9] . The perceived barriers reported in this study would appear to support these recommendations and are similar to reasons for non-uptake recorded among hospital staff in the US [10, 11] .
We have also found that, following careful local promotion, education and taking the point of delivery to ward level, overall uptake was doubled compared with the previous year. This improvement may have been due to [12] . This upturn in influenza infection was also noted locally and coincided with a winter staffing crisis in the host trust. However, one study in general practice patients found that uptake of influenza vaccine in a particular winter was not strongly associated with disease activity in the previous year [13] . Therefore, although local experience of influenza infection may have tended to improve uptake, it is unlikely to explain the 2-fold increase found in this study. There appears to be some scope for further improving influenza immunization rates by adding national awareness campaigns to local initiatives. The potential impact of promotion in the wider NHS is illustrated by our experience in the run-up to the 2000 influenza season. In response to advice from the Department of Health to immunize key health care staff [2] , influenza vaccine was heavily promoted within Southampton University Hospitals NHS Trust in autumn 2000, using a similar approach to that described above. Influenza vaccine was delivered to 600 staff (~10% of all employees) in 2000, a further improvement of >100% on the 1999 flu season.
Anecdotal experience of other NHS OH departments suggests that uptake has been improved even more markedly elsewhere: 20% of all employees were vaccinated in response to intensive promotion in a few NHS trusts However, information offered informally to the Association of NHS Occupational Physicians suggests that other UK trusts achieved uptake rates of the order of 5-15% in the 2000/2001 flu season. These rates are still markedly lower than those reported from the United States, which have mainly been in the region of 10-50% [6, 7, 10, 11, [14] [15] [16] . Clearly, there are important cultural and political differences from the UK, including availability of vaccine from primary care providers and concern over litigation due to nosocomial infection. Despite the encouraging proportional improvement in uptake in this study, only 2-4% of employed doctors and nurses were immunized against influenza following a local campaign. These low rates, despite the specific efforts of the OH department to target front-line clinical care-givers, are disappointing. They suggest that, even with local commitment and the support of national promotion, advice from the Department of Health to immunize key health care workers in the UK is likely to be difficult to achieve in practice.
The poor baseline level of immunization against influenza among employed doctors (<2%) was particularly notable. Again, this differs from the US, where uptake among physicians has been good [10, 11, 14, 15] . It is possible that doctors are more likely to obtain influenza vaccine from their general practitioners or other sources than other staff, thus leading us to underestimate their uptake using OH data. However, we think it unlikely that this has led to major underestimation relative to other staff groups. Moreover, although 41% (50) of new medical recruits expressed intent to take up vaccine, only three of these subsequently did so. It is unlikely that this group of doctors was immunized through other access routes, since new doctors are often slow to register with a local general practice.
Compared with other employees in this study, the increase in vaccine uptake among doctors following active promotion was relatively poor. There are a number of reasons why our immunization campaign might have failed to boost uptake among medical staff. First, the scope for resolving perceived or actual barriers to immunization is more limited than for other staff groups. Access to vaccine, which is relatively amenable to correction, was much less prominent as a barrier for doctors than nurses. The main perceived barrier for medical staff was lack of time, but pressure on doctors' time is a complicated human resource issue in the NHS and local OH departments have limited power to address this barrier directly.
Secondly, it is possible that the mode of promotion was relatively unsuited to medical staff. Doctors may be disinclined to accept health-related messages from nonmedical managers. Moreover, systematic reviews have concluded that the effect of printed educational materials on the clinical practice of doctors appears to be small, but that multi-faceted interventions including messages from opinion leaders (educationally influential peers) and local development of evidence-based policies and consensus processes are likely to have a larger and more practically important impact [17, 18] . This may also be true of information that attempts to change the behaviour of doctors in matters relating to their own health, or to OH Data are missing for two subjects who reported side-effects but did not provide a description. Some subjects reported more than one side-effect.
policy. Therefore, it seems reasonable to suppose that a more complex and science-based promotion campaign delivered by medical peers would be more powerful.
In particular, gaining the support of senior medical managers and clinical role models in promoting influenza immunization to junior doctors might improve vaccine acceptance. Unfortunately, this approach is likely to cost the NHS more than the fairly typical promotion strategy used in this study. The optimum methods of influencing doctors' behaviour highlight an important barrier to uptake among medical staff, namely the inconclusive body of evidence that immunization of fit health care workers against influenza has an important impact on winter pressures. We are able to quote good evidence that immunization with inactivated parenteral vaccine reduces the number of cases of serologically confirmed influenza infection [19] . Moreover, there is some evidence [20, 21] that vaccination of health care workers is associated with reduced mortality among their elderly patients, although it is not entirely clear whether this is due to prevention of influenza [22] . On the other hand, there is only limited evidence that immunization reduces time off work with influenza and any measured fall in sickness absence among health care workers has been modest [23, 24] . More evidence for absence reduction in immunized hospital staff would better equip OH practitioners to develop local evidence-based policies and to gain the support of senior doctors to encourage the compliance of their junior colleagues.
In this study, the incidence of systemic symptoms after influenza immunization was 16% and 14 working days were lost as a result. These figures are slightly lower than the incidence reported from other studies in healthy subjects [19, 25] . However, they do confirm a small but significant morbidity associated with influenza immunization. The costs of promotion, vaccine and lost working days due to side-effects of immunization in fit health care workers must be off-set against any benefits to the individual, their patients and their employer. At present, the literature on overall cost-effectiveness of the routine immunization of health care workers is conflicting. Some studies suggest overall cost benefits [26, 27] , but others conclude that this strategy is unlikely to be cost-effective in most winters [28] . Moreover, most work in this field focuses on potential savings associated with sickness absence, but few take the possible economic impact of reduced nosocomial infection into account. It is clearly likely to be difficult to carry out an accurate assessment of all the financial consequences of vaccinating health care workers. However, some more information on the costeffectiveness of intensive immunization campaigns would be helpful to OH departments that are being asked to justify and resource them.
We conclude that uptake of influenza immunization among fit health care workers can be improved by intensive promotion campaigns. However, uptake rates among key staff, and doctors in particular, are very poor. Moreover, a great deal of effort and resource and a stronger evidence base are the necessary tools to alter uptake behaviour in this group. It is not clear how much sickness absence might be prevented by immunizing healthy employees and therefore how cost-effective such intensive immunization campaigns might be. Further work is needed to ascertain whether immunization of fit health care workers is really cost-effective and whether the resource spent on improving uptake among key clinical staff is worthwhile.
